EXAS (Exact Sciences) EBIT per Share : $-1.05 (TTM As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Exact Sciences EBIT per Share?

Exact Sciences's EBIT per Share for the three months ended in Sep. 2024 was $-0.16. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.05.

During the past 3 years, the average EBIT per Share Growth Rate was 31.40% per year. During the past 5 years, the average EBIT per Share Growth Rate was -4.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was -11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Exact Sciences's EBIT per Share or its related term are showing as below:

EXAS' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55.2 Med: 8.9 Max: 39.7
Current: 31.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Exact Sciences was 39.70% per year. The lowest was -55.20% per year. And the median was 8.90% per year.

EXAS's 3-Year EBIT Growth Rate is ranked better than
83.14% of 172 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.05 vs EXAS: 31.40

Exact Sciences's EBIT for the three months ended in Sep. 2024 was $-29 Mil.

Exact Sciences EBIT per Share Historical Data

The historical data trend for Exact Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Sciences EBIT per Share Chart

Exact Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-3.03

-5.41

-4.84

-3.51

-0.98

Exact Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.04	-0.24	-0.55	-0.10	-0.16

Exact Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Exact Sciences's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-177.325	/	180.144
=	-0.98

Exact Sciences's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-29.155	/	184.795
=	-0.16

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.05

Exact Sciences (NAS:EXAS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Exact Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Exact Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exact Sciences Corp (NAS:EXAS) » Definitions » EBIT per Share

Comparable Companies

CRL QGEN MEDP RDNT RVTY GH SHC NEOG VCYT TWST TMO DHR XSWX:LONN A IQV IDXX MTD ILMN WAT NTRA

Traded in Other Exchanges

EXK:Germany EXK:Germany

Address

5505 Endeavor Lane, Madison, WI, USA, 53719

Website

https://www.exactsciences.com

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Executives

Kevin T Conroy	director, officer: Vice President	5505 ENDEAVOR LANE, MADISON WI 53719
Brian Baranick	officer: Gen. Mgr., Precision Oncology	441 CHARMANY DRIVE, MADISON WI 53719
Jacob A Orville	officer: General Manager, New Ventures	5505 ENDEAVOR LANE, MADISON WI 53719
James Herriott	officer: General Counsel	5505 ENDEAVOR LANE, MADISON WI 53719
Sarah Condella	officer: SVP, Human Resources	441 CHARMANY DRIVE, MADISON WI 53719
D Scott Coward	officer: SVP and General Counsel	441 CHARMANY DRIVE, MADISON WI 53719
Jeffrey Thomas Elliott	officer: Chief Financial Officer	5505 ENDEAVOR LANE, MADISON WI 53719
Everett Cunningham	officer: Chief Commercial Officer	C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Daniel J Levangie	director	85 SWANSON ROAD, BOXBOROUGH MA 01719
James Edward Doyle	director	5505 ENDEAVOR LANE, MADISON WI 53719
Timothy J Scannell	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine S Zanotti	director	431 E 9TH STREET, HINSDALE IL 60521
Paul J Clancy	director	C/O BIOGEN IDEC INC., 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Graham Peter Lidgard	officer: SVP, Chief Scientific Officer	5505 ENDEAVOR LANE, MADISON WI 53719
Michael S Wyzga	director	RADIUS HEALTH, INC., 201 BROADWAY, 6TH FLOOR, CAMBRIDGE MA 02139